In one case, there is likely only a manifestation of the CHEK2 spectrum with colorectal cancer, and the appearance of bladder cancer as a second primary in one of the breast cancer patients could be considered an atypical manifestation. This evidence concerns the gene CHEK2 and urinary bladder cancer.